Neuropsychiatric Disorders and Epigenetics (2nd Ed.) Translational Epigenetics Series
Coordonnateurs : Peedicayil Jacob, Grayson Dennis R.
1. Introduction to Neuropsychiatric Disorders and Epigenetics
2. Environmental Factors and Epigenetics of Neuropsychiatric Disorders
3. Epigenetic Biomarkers in Neuropsychiatric Disorders
4. Epigenetics and Neuroimaging in Neuropsychiatric Disorders
5. Recent advances in genome-wide approaches to biomedical research
6. Single Cell Epigenomic Approaches in Neuropsychiatric Disorders
7. Neuropsychiatric Disorders and Epigenetics: Computational Approaches; Sampling methods; and Power analyses
Section II: Epigenetics of Neuropsychiatric Disorders
8. Epigenetics and Cognitive Disorders -Translational Aspects
9. Epigenetics in Autism Spectrum Disorders - Translational Aspects
10. Epigenetic causes of intellectual disability – the fragile X syndrome paradigm
11. Epigenetics of Attention-Deficit Hyperactivity Disorder
12. The epigenetics of brain aging and psychiatric disorders
13. Epigenetic therapy may alleviate cognitive deficits in Down syndrome by downregulating overexpressed chromosome 21 gene products
14. Epigenetics and Multiple Sclerosis
15. Epigenetics and Migraine
16. The role of epigenetics in the pathophysiology of epilepsy
17. Epigenetic Dysregulation in Brain Tumors and Neurodevelopment
18. Epigenetics and Cerebrovascular Diseases
19. Epigenetics of Spinal Muscular Atrophy and the Potential Role of Epigenetics in the Treatment of this Disorder
20. Epigenetics and Anxiety Disorders
21. Epigenetics and Eating Disorders
22. Epigenetics in Obesity
23. Epigenetics and Drug Addiction-Translational Aspects
24. Epigenetics and Alcohol Use Disorders
Section III: Summary and Outlook
25. Summary and Outlook
Dr Dennis R. Grayson received his PhD from the Department of Biochemistry at Wayne State University School of Medicine in 1984. He has been interested in mechanisms associated with gene expression for over 35 years. He joined the laboratory of Dr James E. Darnell at the Rockefeller University as a Post-Doctoral Fellow in 1984 to study cell-type specific transcription factors and their interaction with promoters and enhancers. In 1988, Dr Grayson joined the Fidia-Georgetown Institute for the Neurosciences at Georgetown University to study gene expression programs in neurons and continued this research program at Allegheny Singer Research Institute
in Pittsburgh from 1995 to 1998. He continued his interests in psychiatry and joined the Psychiatric Institute at the University of Illinois in 1998. This represented a unique opportunity to pursue the molecular underpinnings of schizophrenia. Dr Grayson has received NRSA post-doctoral support, and R01 and K04 funding from the National Institutes of Health to support his work. He has published over 140 papers in peer-reviewed journals and is regularly invited to speak at numerous national and international meetings. He is currently Director of the Epigenetic Core of the Center for Alcohol Research in Epigenetics.
- Analyzes the effects of environmental stimuli on epigenetic states that correlate with neuropsychiatric disease induction
- Reviews the epigenetic basis for common neuropsychiatric disorders, thereby guiding translational therapies for clinicians and mechanistic studies for scientists
- Features extensive use of diagrams, illustrations, tables, and graphical abstracts for each section to reinforce understanding
- Includes chapter contributions from leading global experts
Date de parution : 09-2023
Ouvrage de 416 p.
19x23.4 cm
Thèmes de Neuropsychiatric Disorders and Epigenetics :
Mots-clés :
Aberrant neurogenesis; Acetylation; Alzheimer's disease; Alzheimer's disease; Anxiety; ATRX; Attention deficit; Autism spectrum disorder (ASD); Autoimmunity; Blood; Cardiovascular risk factors; Cerebrovascular diseases; Chromatin; Chromatin remodeler; Demyelination; Diagnosis; DNA hydroxymethylation; DNA methylation; DNA methyltransferase Inhibitors (DNMTi); Dopamine; Down syndrome; Early-life adversity; Early-life stress; Energy balance; Epidrugs; Epigenetic; Epigenetic editing; Epigenetic modifications; Epigenetic programming; Epigenetics; Epigenome; Epigenomics; Epilepsy; FMR1 gene; Fragile X syndrome; Gene expression; Genomics; Glioblastoma; Glioma; Headache; Heterogeneity; Histone; Histone deacetylase inhibitors (HDACi); Histone H3; Histone modification; Histone modifications; Histone tail modifications; HPA axis; Huntington's disease; Hyperactivity; Hypothalamus; IDH; Impulsivity; Inflammation; Intellectual disability; Intellectual disability (ID); Ischemic stroke; Medulloblastoma